Tenorio syndrome: Description of 14 novel cases and review of the clinical and molecular features
- PMID: 34196401
- DOI: 10.1111/cge.14020
Tenorio syndrome: Description of 14 novel cases and review of the clinical and molecular features
Abstract
Tenorio syndrome (TNORS) (OMIM #616260) is a relatively recent disorder with very few cases described so far. Clinical features included macrocephaly, intellectual disability, hypotonia, enlarged ventricles and autoimmune diseases. Molecular underlying mechanism demonstrated missense variants and a large deletion encompassing RNF125, a gene that encodes for an U3 ubiquitin ligase protein. Since the initial description of the disorder in six patients from four families, several new patients were diagnosed, adding more evidence to the clinical spectrum. In this article, we described 14 additional cases with deep phenotyping and make an overall review of all the cases with pathogenic variants in RNF125. Not all patients presented with overgrowth, but instead, most patients showed a common pattern of neurodevelopmental disease, macrocephaly and/or large forehead. Segregation analysis showed that, though the variant was inherited in some patients from an apparently asymptomatic parent, deep phenotyping suggested a mild form of the disease in some of them. The mechanism underlying the development of this disease is not well understood yet and the report of further cases will help to a better understanding and clinical characterization of the syndrome.
Keywords: RNF125; Tenorio syndrome; genomic medicine; macrocephaly; neurodevelopmental; overgrowth; ring-finger; ubiquitin ligase.
© 2021 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Lapunzina P. Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet. 2005;137C:53-71.
-
- Tenorio J, Mansilla A, Valencia M, et al. A new overgrowth syndrome is due to mutations in RNF125. Hum Mutat. 2014;35:1436-1441.
-
- Biesecker LG, Sapp JC. Proteus Syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews([R]). Seattle (WA); 1993.
-
- Keppler-Noreuil KM, Rios JJ, Parker VE, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015;167A:287-295.
-
- Gordo G, Tenorio J, Arias P, et al. mTOR mutations in smith-Kingsmore syndrome: four additional patients and a review. Clin Genet. 2018;93:762-775.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
